Accumulating evidence suggests that PRDX2 overexpression is implicated in tumorigenesis and the progression of various inflammatory diseases, including psoriasis, inflammatory bowel disease, and RA. This evidence concerns the gene PRDX2 and inflammatory bowel disease.